Magnetically Responsive Microbubbles as Delivery Vehicles for Targeted Sonodynamic and Antimetabolite Therapy of Pancreatic Cancer

Sheng, Yingjie and Beguin, Estelle and Nesbitt, Heather and Kamila, Sukanta and Owen, Joshua and Barnsley, Lester and Callan, Bridgeen and O'Kane, Christopher and Nomikou, Nikolitsa and Hamoudi, Rifat and Taylor, Mark and Love, Mark and Kelly, Paul and O'Rorke, Declan and Stride, Eleanor and McHale, Anthony and Callan, John (2017) Magnetically Responsive Microbubbles as Delivery Vehicles for Targeted Sonodynamic and Antimetabolite Therapy of Pancreatic Cancer. Journal of Controlled Release. ISSN 1873-4995

[img] Text
Accepted Version
Restricted to Repository staff only until 29 July 2018.
Available under the following license: Creative Commons Attribution Non-commercial No Derivatives.

Download (661kB)
[img] Other (Acceptance)
Other
Restricted to Repository staff only

Download (91kB)
Official URL: https://doi.org/10.1016/j.jconrel.2017.07.040

Abstract

Magnetically responsive microbubbles (MagMBs), consisting of an oxygen gas core and a phospholipid coating functionalised with Rose Bengal (RB) and/or 5-fluorouracil (5-FU), were assessed as a delivery vehicle for the targeted treatment of pancreatic cancer using combined antimetabolite and sonodynamic therapy (SDT). MagMBs delivering the combined 5-FU/SDT treatment produced a reduction in cell viability of over 50% when tested against a panel of four pancreatic cancer cell lines in vitro. Intravenous administration of the MagMBs to mice bearing orthotopic human xenograft BxPC-3 tumours yielded a 48.3% reduction in tumour volume relative to an untreated control group (p<0.05) when the tumour was exposed to both external magnetic and ultrasound fields during administration of the MagMBs. In contrast, application of an external ultrasound field alone resulted in a 27% reduction in tumour volume. In addition, activated caspase and BAX protein levels were both observed to be significantly elevated in tumours harvested from animals treated with the MagMBs in the presence of magnetic and ultrasonic fields when compared to expression of those proteins in tumours from either the control or ultrasound field only groups (p<0.05). These results suggest MagMBs have considerable potential as a platform to enable the targeted delivery of combined sonodynamic / antimetabolite therapy in pancreatic cancer.

Item Type: Journal Article
Keywords: microbubbles, magnetic targeting, drug delivery, hypoxia, 5-fluoruracil, rose bengal, sonodynamic therapy, antimetabolite therapy, pancreatic cancer
Faculty: Faculty of Science & Technology
Depositing User: Unnamed user with email Christopher.OKane@anglia.ac.uk
Date Deposited: 15 Aug 2017 13:58
Last Modified: 15 Aug 2017 13:58
URI: http://arro.anglia.ac.uk/id/eprint/702081

Actions (login required)

Edit Item Edit Item